Discrimination may speed up the biological processes of aging, according to a new study led by researchers at the NYU School of Global Public Health.
FDA puts partial hold on Gilead’s CD47 hopeful in AML
The FDA put a partial clinical hold on Gilead’s magrolimab for acute myeloid leukemia, a month after the company scrapped late-stage development of the CD47
August 22, 2023